Results 31 to 40 of about 9,878 (194)

Prevalence of SSRI/SNRI use per 100 pregnancies in the Nordic population by trimester.

, 2015
Preg, pregnancy * at least one dispensed SSRI/SNRI during relevant time window per 100 pregnancies ** whole pregnancy = at least one dispensed SSRI or SNRI during each trimester of pregnancy, including 90 days period before ...
Mette Nørgaard (65616), Unnur Valdimarsdottir (2580412), Lena Brandt (836854), Bengt Haglund (836855), Helle Kieler (836853), Kari Furu (238283), Helga Zoega (2580418)   +6 more
core   +1 more source

Melatonin Levels in 89 Individuals With Smith Magenis Syndrome

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT In patients with Smith–Magenis syndrome (SMS), an inverted circadian rhythm of melatonin (MT) contributes to the sleep disturbance. Standard treatment of sleep disturbance with MT often leads to extremely high daytime MT levels, resulting in even more sleep disorders. We therefore retrospectively evaluated the MT data of 89 SMS patients.
Wiebe Braam, Ann C. M. Smith
wiley   +1 more source

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history

Неврология, нейропсихиатрия, психосоматика, 2018
Based on the data available in the literature, the author has first systematized in detail the main stages of the design and clinical introduction of serotonin and norepinephrine reuptake inhibitor (SNRI) antidepressants.
D. S. Danilov
doaj   +1 more source

Linking Brain Morphometry to Psychometric Measures and Energy‐Metabolic Biomarkers in Adults With Autism Spectrum Disorder

Autism Research, EarlyView.
ABSTRACT Autism spectrum disorder (ASD) is associated with differences in neurodevelopment and altered metabolism, yet the interplay between brain morphometry, mitochondrial and energy metabolism biomarkers, and autistic traits in adults remains poorly understood. This study investigates the link between brain structure, psychometric measures, and both
Eleonora Esposto, Kathrin Nickel, Dominique Endres, Kimon Runge, Katharina Domschke, Thomas Lange, Marco Reisert, Anke Schumann, Cinzia Niolu, Ludger Tebartz van Elst, Simon Maier   +10 more
wiley   +1 more source

sj-docx-2-jop-10.1177_02698811231179910 – Supplemental material for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use

, 2023
Supplemental material, sj-docx-2-jop-10.1177_02698811231179910 for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use by Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis G. Antoine and Sandeep M. Nayak in
Natalie Gukasyan (9965504), David B. Yaden (10346130), Sandeep M. Nayak (12300269), Denis G. Antoine (16286642), Roland R. Griffiths (6623057)   +4 more
core   +1 more source

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le, Sabrina Wong, Danica E. Johnson, Diana K. Orsini, Yang Jing Zheng, Kayla M. Teopiz, Christine E. Dri, Joshua D. Rosenblat, Roger S. McIntyre   +8 more
wiley   +1 more source

Antidepressants for social anxiety disorder: A systematic review and meta‐analysis

Neuropsychopharmacology Reports, 2022
Aim This systematic review is aimed to update and reintegrate the pharmacotherapy of social anxiety disorder (SAD), including the Japanese medical database. Methods We conducted a systematic review and meta‐analysis of pharmacotherapy of SAD according to
Nobuyuki Mitsui, Yutaka Fujii, Satoshi Asakura, Hissei Imai, Hisashi Yamada, Naoki Yoshinaga, Yoshihiro Kanai, Takeshi Inoue, Eiji Shimizu   +8 more
doaj   +1 more source

Associations Between Microbial Depletion and Autonomic Dysregulation in Binge‐Eating Disorder

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective The interplay between the gut microbiome and autonomic nervous system remains unexplored in binge‐eating disorder (BED). We aimed to explore specific microbial alterations in BED and examine their potential association with cardiac vagal tone as a distinct bio‐behavioral phenotype.
Shuang Liang, Esben Strodl, Leanne Barron, Matthew Bambling, Luis Vitetta   +4 more
wiley   +1 more source

sj-docx-1-jop-10.1177_02698811231179910 – Supplemental material for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use

, 2023
Supplemental material, sj-docx-1-jop-10.1177_02698811231179910 for Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use by Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis G. Antoine and Sandeep M. Nayak in
Natalie Gukasyan (9965504), David B. Yaden (10346130), Sandeep M. Nayak (12300269), Denis G. Antoine (16286642), Roland R. Griffiths (6623057)   +4 more
core   +1 more source

Psychotropic Drugs in Dermatology Part 1: Anti-depressants and Mood Stabilisers

Indian Journal of Dermatology
Psycho-dermatology is an evolving speciality of psychosomatic medicine where psychological factors play a role in initiating and/or exacerbating the dermatological conditions.
Varsha L. Kenkare, Bhushan Madke, Ankita Choudhary, Shiti Bose   +3 more
doaj   +1 more source